Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
Montopoli et al., Annals of Oncology, doi:10.1016/j.annonc.2020.04.479
https://c19early.org/montopoli.html